Lactating goats and sheep were fitted with catheters in the external pudendal arteries supplying both mammary glands. Saline was infused continuously into one artery whereas the other artery received continuous infusions, over successive 4-day periods, of either saline or growth hormone (GH)-doses increasing twofold between successive periods from 100 to 400 ltg/day in goats and 400 to 3200 Itg/ day in sheep.
Introduction
Although it is well documented that growth hormone (GH) increases milk production in cows Bines et al. 1980; Peel et al. 1981 Peel et al. , 1982 , sheep (Dracy and Jordan 1954; Jordan and Shaffhausen 1954; Hart et al. 1985) and goats Mepham et al. 1984) , the mechanisms by which the hormone exerts galactopoietic effects remain unclear. Bines et al. (1980) and also raised the possibilities that GH acts directly or indirectly on the mammary gland or, alternatively, influences the supplies of key nutrients to the mammary gland, thereby influencing the capacity of the mammary gland to synthesize milk.
The present studies were conducted to establish whether GH exerts direct effects on the mammary glands of lactating sheep and goats. Preliminary results of studies in lactating sheep were reported by McDowell and Hart (1984) .
Materials and Methods

Experimental Animals
The three primiparous British Saanen goats and five primiparous English Halfbred ewes were free from obvious abnormalities of the mammary glands. Goats were housed in small pens whereas the sheep were kept in metabolism cages. Both sheep and goats were fed a diet containing 60 : 40 (w : w) sheep pellets (BOCM): chopped pasture hay in sufficient quantities to meet calculated requirements for 0004-9417/87/020181$02.00 metabolizable energy (Anon. 1975) . The daily allocation was offered in approximately equal portions at milking times (0830 and 1600 h each day) and water was available ad libitum.
All animals were accustomed to handling and could be bled (from jugular catheters) and milked without restraint. As the sheep had not been milked previously, 1 Lu. oxytocin (Sandoz, Basel, Switzerland) was administered intravenously via the jugular catheter immediately prior to each milking throughout the experiment.
Studies with the goats were conducted during summer (June/July) when they had been lactating for 10-14 weeks. The studies on sheep were conducted during winter (December-March) and commenced about 10 days after lambing.
Surgical Preparation of Animals
Polyvinyl chloride catheters (0'86 mm Ld. by 1·27 mm o.d.; Dural Plastics Ltd, Dural, N.S.W. 2158, Australia) were inserted in both external pudendal arteries of each goat and sheep under halothane anaesthesia. The catheters were tunnelled beneath the skin to exit points high on the back and posterior to the rib cage. An additional polyvinyl chloride catheter (1' 0 mm Ld. by 1· 5 mm o.d.; Dural Plastics Ltd) was inserted in an external jugular vein of each animal while the animal was anaesthetized. Catheters were kept patent by flushing with minimum amounts of heparinized saline (2 x 10 5 Lu. heparin and 9·0 g NaCI per litre).
All animals recovered from surgery within 5-7 days by which time feed intakes and milk yields had returned to the levels before surgery. The animals remained in good health throughout the experiments.
Analytical Procedures
Milk constituents Milk fat, protein and lactose were measured using a Milko-Scan 203 (A/S N Foss Electric, Denmark) after appropriate calibration of the instrument with sheep or goat milk.
Plasma hormones
Insulin and GH were measured using the radioimmunoassays described by Tindal et al. (1978) . Concentrations of insulin and GH were expressed relative to the standards bovine insulin (24 i.u.lmg) and bovine GH (NIH-GH-B2; 1·5 U/mg) respectively. The sensitivities of the assays were 0·4 mUll and o· 2 /Lg/l for insulin and GH respectively. Assays were considered valid if the intra-assay coefficient of variation was less than 15%. To reduce variation stemming from differences between assays, all samples from a single experiment were measured in the same assay.
Plasma metabolites
Glucose and urea were assayed simultaneously in untreated plasma samples using a dual channel ChemLab Autoanalyser as outlined by the manufacturer (ChemLab Instruments Ltd, Hornchurch, Essex, U.K.). Plasma non-esterified fatty acids (NEFA) were assayed by the microtitration procedure described by Kelley (1965) .
Infusates
Saline (9 g NaCl/I) was sterilized by autoclaving. Appropriate quantities of bovine GH were dissolved in sterile saline adjusted to pH 10 with 1 M NaOH. Benzylpenicillin (Glaxo Laboratories Ltd, Greenford, U.K.; 1·67 x 10 3 U/mg) was added to infusates at the rate of 1 mg/ml, and infusates were dispensed into sterile reservoirs with capacity to contain sufficient infusate for 24 h. Bacteriological analyses confirmed the absence of bacteria from infusates.
Bovine Growth Hormone
Different preparations of bovine GH were used. In the experiment with goats NIH-GH-BI8 (0·81 U/mg) was used whereas in the experiment with sheep a preparation extracted on site (ICH/ bGH/5; 1· 2 U/mg) was used. The preparations elicited similar galactopoietic effects in sheep and goats when administered subcutaneously at a dose rate of 0·081 U/kg live weight. At this dose milk yields of both sheep and goats increased by 10-15%.
Experimental Procedures
Prior to surgery, the sheep and goats were trained to wear harnesses onto which were attached pouches containing infusate reservoirs and a battery-operated peristaltic pump (SIRO pump; Everest Electronics, Seaford, South Australia). When the animals had recovered from surgery, the experiment commenced.
Saline was infused continuously into one external pudendal artery for the duration of the experiment. The other artery received continuous infusions, over alternate periods of 4 days, of either saline or GH. Throughout the experiments, daily doses of GH increased twofold between successive GH infusion periods. Daily doses for goats were 100, 200 and 400 ltg/day whereas doses for sheep were 400, 800, 1600 and 3200 ltg/day. Infusion rates of 5 mllh were maintained for saline and the GH infusates.
At the conclusion of the infusions to the sheep the galactopoietic potency of the preparation of GH was assessed. Immediately after the last period of saline infusions, each ewe was given a daily subcutaneous injection of O· 1 mg/kg liveweight GH for 4 days, then for a further 4 days a daily subcutaneous injection of saline (pH 10'0). Milk yield and composition, together with plasma concentrations of metabolites and hormones were measured during each of these periods of 4 days.
Goats were milked by hand whereas sheep were milked by machine. Milk from each udder half of each animal was collected separately, pooled over 24 h, weighed and a subsample kept at 4°C after addition of formalin (100 gil; 3 drops/1O ml milk) as preservative, pending subsequent weekly analyses.
Blood samples were collected from the jugular catheters on day 2 or 3 of each period of the experiments each hour between 1000 and 1500 h. Heparin was used as anticoagulant and plasma separated at 4°C within 10 min of collection was stored at -20°C pending analyses for glucose, urea, NEFA, GH and insulin.
Statistical Analyses
Comparisons between values for the parameters measured during individual periods (4 days) of each infusion experiment were analysed by analysis of variance treating the experiments as split plots in time. Differences between mean values for parameters measured during the injection of GH or saline were assessed by paired t-tests. 
Results
Milk Yield and Composition
Mean milk yields during infusions are shown in Fig. 1 . Although there were significant trends (P < 0·05) over the period of the experiment (yields of goats increased and those of sheep decreased), there were no significant differences (P > 0·05) between yields of glands given continuous intra-arterial infusions of saline (control glands) and those given alternating intra-arterial infusions of saline and GH (treated glands). It appeared that the yields of both control and treated glands of the sheep increased during infusion of GH of 3200 p.g/day but these changes were not significant (P > 0·05). During injection of sheep with GH, milk yield increased significantly (P < 0·05) from 644 ± 41·7 g/day (mean ± s.e.m.) during the last period of saline infusion to 724 ± 27·7 g/ day. Yield then decreased significantly (P < 0·05) to 659 ± 28·2 g/ day during the 4 days when saline was injected.
No significant (P > 0·05) effects of GH infusions on milk composition were measured in sheep and goats. However, there were changes in composition of milk from both treated and control glands throughout the experiments. In the goats, there were significant changes over the period of the experiment (P < 0·05) in contents of milk fat and protein in both control and treated glands. Contents of milk fat decreased from c. 42 to 38 g/kg and milk protein decreased from c. 31 to 29 g/kg over the 28 days of the experiment. Milk lactose content remained essentially constant at c. 45·5 g/kg. Similar trends for changes in milk composition were recorded for the sheep.
Milk fat content, although very variable, decreased significantly (P < 0·001) from c. 80 to 70 g/kg and milk lactose decreased significantly (P < 0·001) from c. 47 to 44 g/kg throughout the experiment. No significant (P > O· 05) changes were measured for milk protein content which remained at c. 60 g/kg.
In the sheep injections of GH did not affect lactose and protein contents of milk which remained at c. 44 g/kg and 60 g/kg respectively. There was, however, a significant effect (P < 0·05) of GH injection on milk fat. Values were 70·3 ± 3·62 g/kg (saline infusion) 77·9 ± 2·62 g/kg (GH injection) and 71·4 ± 2'18 g/ kg (saline injection) during the respective periods of 4 days.
Plasma Hormones Growth hormone
Mean daily values, on the second or third day of each period of infusions are shown in Fig. 2 . In the goats, there were no significant differences (P> 0 ·1) between values for plasma GH in individual periods. However, in general, values were lower (P < 0·1) during GH infusion than control periods. For the sheep, plasma concentrations of GH were significantly increased (P < 0·001) during infusion of GH of 3200 p.g/day and also during the last control period. Values for all other periods were similar (c. 2·5 p.g/l).
Plasma GH increased significantly (P < 0·05) during injections of GH in the sheep. Values were 5·2 ± 0·74 p.g/l (saline infusion), 11·0 ± 0·77 p.g/l (GH injection) and 3·3 ± 1·08 p.g/l (saline injection) respectively. In both goats and sheep plasma insulin concentrations remained relatively stable (goats 22-27 mUll; sheep 14-20 mUll) throughout the experiments. There were no effects of GR infusions in either sheep or goats. Similarly injections of GR did not affect plasma insulin which remained at c. 20 mUll. Growth hormone dose (/Lg/day)
Plasma Metabolites
Glucose and urea Growth hormone infusions had no effects (P> O· 1) on plasma concentrations of glucose and urea. Mean daily concentrations of glucose were c. 3· 5 and c. 4·0 mM for goats and sheep respectively. Corresponding values for plasma urea were c. 5·1 and 5·0 mM respectively. There were no effects of GR injections or plasma glucose and urea in the sheep. Concentration of glucose remained at c. 4 mM and urea c. 5 mM.
Non-esterified Fatty Acids
Mean concentrations of plasma NEF A on the second or third day of each period of respective infusions are shown in Fig. 3 . There were no 'significant effects (P> 0'1) of GR infusions on plasma concentrations of NEFA in the goats. Similarly, in the sheep differences between values for respective periods were not significant (P> 0·1). In spite of the latter, mean daily concentrations tended to be higher during GR than saline infusions. Indeed, for the sheep comparison of values for control and GR-infusion periods, combined for all doses of GR, indicated a significant (P < 0'1) effect of GR infusion.
Plasma NEF A were similar in the sheep during the last saline infusion period (323 ± 89 pM) and during injection of GR (319 ± 111 I'M), and although the mean value during injection of saline (232 ± 17 I'M) was lower, differences were not significant (P > O· 05).
Discussion
A number of authors have raised the possibility that GR exerts direct effects on the mammary glands of ruminants (Bines et al. 1980; Peel et al. 1980; Eppard and Bauman 1984) . Mepham et al. (1984) discussed the suggestion that GR, either directly or indirectly, affects metabolic activity of mammary secretory cells and as a result the local production of vasodilators such as kallidin and bradykinin (Dhondt et al. 1973) . Such an effect might explain the increase in mammary blood flow during treatment of goats (Mepham et al. 1984) and cows (McNamara et al. 1983) with GR.
Although, as outlined above, increased mammary blood flow has been reported, it is considered unlikely that this is due to an effect (direct or indirect) of GR on mammary tissue. Mepham et al. (1984) , in discussing the cause of increased mammary blood flow in goats given galactopoietic doses of GR, considered that increased blood pressure, arising from increased cardiac output, would explain the increase measured in their experiments. Recent evidence from studies with lactating cows suggests that cardiac output increases during treatment with GR . In these studies with cows blood flow to the mammary gland and to muscle tissue of the hind limb increased by c. 20% -a similar increase was observed in milk production.
The present results show that local infusion of a galactopoietic preparation of GR in low doses failed to affect milk production and composition in goats and sheep. Doses of GR infused were chosen with the view to increasing local, but not peripheral, concentrations of hormone. Although no measurements were made of local tissue concentrations or concentrations in venous blood draining infused glands, it is reasonable to assert that local concentrations would have increased during infusions.
Given that the blood flow: milk yield ratio for the mammary gland approximates 500: 1 (see Linzell 1974) and concentrations of GR in peripheral blood of 2,5-5· 0 JLg/l for goats and 2· 5 JLg/l for sheep (see Fig. 2 ), it is possible to estimate rates of 'exposure' of mammary tissue to GH. In the goats, basal exposure rates would have ranged from c. 800 to 1600 ng/min (depending on peripheral concentration) and infusion of GH would have increased exposure by c. 5-30% (from 100 to 400 p.g/day). In the sheep, basal rates of exposure were c. 280 ng/min and infusions of GH would have increased exposure from twofold (400 p.g/day) to nearly tenfold (3200 p.g/day).
It might be argued that interchange of blood between udder halves of the sheep and goats would have increased exposure of control glands to GH. Although it has been established that collateral circulation does occur (see Linzell 1974 ), it appears that interchange of blood is trivial in view of results obtained by McBride and Christopherson (1984) . These workers measured blood flows of individual udder halves of lactating ewes by infusion of radiolabelled micro spheres into the arterial blood supplying these individual udder halves. Insignificant amounts of radioactivity were detected in tissues of contralateral udder halves, thereby indicating trivial interchange of blood between halves of the udder.
With the exception of the period when 3200 p,g/ day were infused, peripheral plasma concentrations of GH were unaffected by infusions. Similarly, in the main, plasma concentrations of insulin, glucose, urea and NEF A were unaffected by GH infusions.
In connection with the latter, GH is known to exert diabetogenic and lipolytic effects (Hart 1983) and to promote muscle protein synthesis (Lindsay 1983 ).
Indeed, it has been shown by Bines et at. (1980) that plasma concentrations of insulin, glucose and NEF A increase, whereas plasma urea decreases, in lactating cows exhibiting a galactopoietic response to GH. Failure to measure changes in concentrations of plasma insulin and metabolites during infusions of GH is, therefore, consistent with there being no increase in peripheral concentration of GH.
The exception to the above occurred during infusion of GH at 3200 p.g/ day into sheep. Plasma concentrations of GH were increased approximately threefold and there was a tendency for plasma concentrations of NEF A to increase (see Figs 2 and 3). Inexplicable increases in plasma concentrations of both GH and NEFA were measured during the last period of the sheep experiment when saline was infused into both mammary arteries.
There was a tendency for milk yields, of both GH-infused and saline-infused mammary glands, to increase during infusion of GH of 3·2 mg/day into the sheep. This dose approaches that of O· 1 mg/ day per kilogram live weight (5·5 mg/ day) found by McDowell and Hart (unpublished data) to increase milk yields of lactating sheep by 10-15% when the hormone was administered as either a single subcutaneous injection each day or as a continuous intravenous infusion. Indeed, the subcutaneous injections of GH given to sheep (dose of O· 1 mg/ day per kilogram liveweight) significantly increased milk yield.
Our results are consistent with results of in vitro studies. Skarda et at. (1982) found that GH did not affect synthetic activity of cultured mammary tissue from pregnant goats. Similarly, Gertler et at. (1983) reported that syntheses of casein, fat and a-lactalbumin in cultured explants of bovine mammary tissue were not affected by ovine nor bovine GH. Moreover, it appears that receptors for bovine GH are not present in caprine mammary tissue (Mikulash et at. 1981) .
In conclusion, the results of the present studies indicate that GH does not directly stimulate the mammary gland to produce additional milk. Notwithstanding the foregoing results, it is possible that GH may affect turnover of the mammary epithelial cells and/or the biochemical activity of the epithelial cells, as suggested by Eppard and Bauman (1984) , when the hormone is administered over prolonged periods. However, it should be remembered that the milk yield response to subcutaneous GH normally is measured within 1-2 days of treatment. It is also possible that a direct effect on the mammary gland may be mediated by secondary factors (e.g. somatomedins) which are subject to GH control.
